Large Gynecological Disease Patient Pool Pointing to Robust Growth Opportunities
According to the Centers for Disease Control and Prevention (CDC), U.S., women are at risk for developing uterine cancers and the probability increases with age. Furthermore, uterine fibroids (leiomyomas or myomas) are the most common benign pelvic tumours in women. It is estimated that 80% of women develop uterine fibroids during their lifetime. Similarly, unhealthy lifestyles are increasing the prevalence of polycystic ovary disease (PCOD) in adolescent women. The aforementioned factors along with increased risk of postmenopausal complications in older women is expected to propel the hysteroscopy systems market growth during the forecast period.
Awareness for Hysteroscopy Procedures to Spike, on the Back of Increasing Reimbursement Policies
Gradual shift in reimbursement policies has pumped up the prevalence of hysteroscopy in office-based set-ups. As per the report of national payment amounts, consumer spending on hysteroscopy procedures performed in office has increased threefold, accounting for an average of US$ 1,382.1 in 2017 as compared to US$ 409.6 in 2016.
Furthermore, increasing awareness among people is playing an important role in the overall growth of the market. Several awareness programs such as “My hysteroscope is my Stethoscope” are encouraging gynecologists to use hysteroscopy as a diagnostic tool. In recent years, office-based hysteroscopes are gaining popularity, thus creating new and robust opportunities for growth of the hysteroscopy systems market.
North America and Europe to Maintain Hegemony as FDA Amps up Regulations
North America along with Europe together accounted for nearly half of the market share in the hysteroscopy systems market. The increased adoption of hysteroscopy systems in the North America is attributable to the replacement of traditional methods with hysteroscopy and encouragement of office based hysteroscopy procedures. This offers lucrative opportunities for growth of the market in these regions. Furthermore, initiatives by the regulatory authorities will further heighten the demand for hysteroscopy systems. For instance, in April 2018, the FDA ordered restrictions on the sale and distribution of Essure, a device for female sterilization. This was done to ensure that all women are provided with adequate risk information to make informed decisions. Such directives will propel the market growth in these regions.
For strategic insights on the hysteroscopy systems market, request for a report sample here
Hysteroscopy Systems Market Poised for Consolidation, Top Players Capture 80% Market Share
The hysteroscopy systems market is a consolidated market with top five companies holding a market share of nearly 80%. Most of the top players already have a strong foothold in the endoscopy market, as compared to newer participants. Although, these companies offer strong competition for new entrants. Some companies such as Meditrina Inc. have been able to develop advanced products that will be launched into the market by the end of 2019. The hysteroscopy systems market currently holds ~6% of the endoscopy systems market. This trend is expected to change with hysteroscopy taking over 10% of the endoscopy market primarily due to the rapid adoption of hysteroscopy systems and replacement of traditional procedures with hysteroscopic procedures.
For strategic insights on the competition landscape of the hysteroscopy systems market, ask an analyst here
Acquisitions, a Key Trend Burgeoning Hysteroscopy System Market Growth
Most manufacturers are focusing on acquiring technology developed by competitors to enhance their product portfolio. Although the hysteroscopy systems market is consolidated, new players are working in the market by launching number of hysteroscopy systems and accessories
- In 2016, Medtronic plc acquired Smith & Nephew's gynecology business for approximately US$350 million. Medtronic acquired TRUCLEAR System, Smith & Nephew's key GYN solution, through this agreement
- Meditrina Inc. founded in 2016, expects Aveta™ System to be launched by the end of 2019. After the FDA approval for Aveta, the company received US$ 13 Mn equity financing led by ShangBay Capital LLC and Aethan Capital, Inc. This reflects the growth potential the hysteroscopy systems market holds during the forecast period.
Request research methodology of this report.
Hysteroscopy Systems Market - Scope of the Report
Fact.MR recently published a market study on the global market for hysteroscopy systems. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the hysteroscopy systems market structure. The market study presents exclusive information about how the hysteroscopy systems market will grow during the forecast period of 2019-2029.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the hysteroscopy systems market during the forecast period.
The study is relevant for stakeholders in the hysteroscopy systems market, including hysteroscopy systems manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the hysteroscopy systems market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.
The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the hysteroscopy systems market. Furthermore, small businesses and new entrants in the Hysteroscopy Systems Market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.
Key Segments of the Hysteroscopy Systems Market
Fact.MR’s study on the hysteroscopy systems market offers information divided into four important segments - Product, Modality, End User, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
|
Product |
|
|
Modality |
|
|
End User |
|
|
Region |
|
Key Questions Answered in Fact.MR ’s Hysteroscopy Systems Market Report
- Which regions will continue to remain the most profitable regional markets for hysteroscopy systems market players?
- Which factors will induce a change in the demand for hysteroscopy systems manufacturers during the assessment period?
- How will changing trends impact the hysteroscopy systems market?
- How can market players capture the low-hanging opportunities in the hysteroscopy systems market in developed regions?
- Which companies are leading the hysteroscopy systems market?
- What are the winning strategies of stakeholders in the hysteroscopy systems market to upscale their position in this landscape?
Hysteroscopy Systems Market: Research Methodology
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the hysteroscopy systems market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.
Secondary resources referred to analysts during the production of the Hysteroscopy Systems Market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the hysteroscopy systems market, and makes Fact.MR’s projection on the growth prospects of the hysteroscopy systems market more accurate and reliable.
1. Executive Summary
1.1. Global Market Outlook
1.2. Technology Advancements
1.3. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
4. Key Success Factors
4.1. SWOT Analysis
4.2. Parent Market Analysis
4.3. Adoption Analysis
4.4. Key Product USP Analysis
4.5. Regulatory Scenario
4.6. Reimbursement Scenario
5. Global Hysteroscopy Systems Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Hysteroscopy Systems Market - Pricing Analysis
6.1. Regional Pricing Analysis By Components
6.2. Global Average Pricing Analysis Benchmark
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Consolidation of Healthcare Industry
7.1.2. Medical Device Industry Outlook
7.1.3. Domestic Manufacturing Efforts
7.2. Forecast Factors - Relevance & Impact
7.2.1. Increase in number of gynecology procedures
7.2.2. Advancements in Technology
7.2.3. Rise in R&D funding
7.2.4. Increasing number of clinics
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029
8.3.1. Hysteroscopes
8.3.1.1. Flexible Video Hysteroscopes
8.3.1.2. Non-Video Hysteroscopes
8.3.1.2.1. Rigid Non-Video Hysteroscopes
8.3.1.2.2. Flexible Non-Video Hysteroscopes
8.3.2. Hysteroscopy Fluid Management Systems
8.3.3. Hysteroscopic Tissue Removal Systems
8.4. Market Attractiveness Analysis By Product Type
9. Global Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029, by Modality
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Modality, 2014 - 2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Modality, 2019 - 2029
9.3.1. Bench-Top Systems
9.3.2. Standalone Systems
9.3.3. Handheld Systems
9.4. Market Attractiveness Analysis By Modality
10. Global Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2018
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Office-based Hysteroscopy
10.3.4. Ambulatory Surgical Centres
10.4. Market Attractiveness Analysis By End User
11. Global Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Modality, 2014 - 2018
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis By Region
12. North America Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Modality
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.5. Drivers and Restraints - Impact Analysis
13. Latin America Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Argentina
13.3.1.3. Mexico
13.3.1.4. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Modality
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Europe Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
14.3. Market Size (US$ Mn) and By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. Russia
14.3.1.7. Rest of Europe
14.3.2. By Product Type
14.3.3. By Modality
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. South Asia Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Modality
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. East Asia Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Modality
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Drivers and Restraints - Impact Analysis
17. Oceania Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Modality
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Modality
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
19. Emerging Countries Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. China Hysteroscopy Systems Market Analysis
19.2.1. Introduction
19.2.2. PEST Analysis
19.2.3. Market Value Proportion Analysis by Market Taxonomy
19.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.2.4.1. By Product Type
19.2.4.2. By Modality
19.2.4.3. By End User
19.3. India Hysteroscopy Systems Market Analysis
19.3.1. Introduction
19.3.2. PEST Analysis
19.3.3. Market Value Proportion Analysis by Market Taxonomy
19.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.3.4.1. By Product Type
19.3.4.2. By Modality
19.3.4.3. By End User
19.4. Brazil Hysteroscopy Systems Market Analysis
19.4.1. Introduction
19.4.2. PEST Analysis
19.4.3. Market Value Proportion Analysis by Market Taxonomy
19.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.4.4.1. By Product Type
19.4.4.2. By Modality
19.4.4.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Medtronic plc
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Channel/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.1.5.1. Marketing Strategy
21.2.1.5.2. Product Strategy
21.2.1.5.3. Channel Strategy
21.2.2. KARL STORZ SE & Co KG
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/Channel/Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.2.5.1. Marketing Strategy
21.2.2.5.2. Product Strategy
21.2.2.5.3. Channel Strategy
21.2.3. Olympus Corp
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/Channel/Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.3.5.1. Marketing Strategy
21.2.3.5.2. Product Strategy
21.2.3.5.3. Channel Strategy
21.2.4. Stryker Corp
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/Channel/Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.4.5.1. Marketing Strategy
21.2.4.5.2. Product Strategy
21.2.4.5.3. Channel Strategy
21.2.5. Richard Wolf GmbH
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/Channel/Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.5.5.1. Marketing Strategy
21.2.5.5.2. Product Strategy
21.2.5.5.3. Channel Strategy
21.2.6. Hologic, Inc.
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/Channel/Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.6.5.1. Marketing Strategy
21.2.6.5.2. Product Strategy
21.2.6.5.3. Channel Strategy
21.2.7. Cooper Surgical Inc.
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/Channel/Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.7.5.1. Marketing Strategy
21.2.7.5.2. Product Strategy
21.2.7.5.3. Channel Strategy
21.2.8. World of Medicine Lemke GmbH
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product/Channel/Region)
21.2.8.4. Sales Footprint
21.2.8.5. Strategy Overview
21.2.8.5.1. Marketing Strategy
21.2.8.5.2. Product Strategy
21.2.8.5.3. Channel Strategy
21.2.9. Boston Scientific
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product/Channel/Region)
21.2.9.4. Sales Footprint
21.2.9.5. Strategy Overview
21.2.9.5.1. Marketing Strategy
21.2.9.5.2. Product Strategy
21.2.9.5.3. Channel Strategy
21.2.10. Meditrina Inc.
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product/Channel/Region)
21.2.10.4. Sales Footprint
21.2.10.5. Strategy Overview
21.2.10.5.1. Marketing Strategy
21.2.10.5.2. Product Strategy
21.2.10.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Hysteroscopy Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029